Thank you for Subscribing to Food Business Review Weekly Brief
Food Business Review | Tuesday, August 11, 2026
A supplement label can pass several internal reviews and still fail when a regulator, retailer, marketplace or advertising platform applies a different reading. The risk rarely begins with typography alone. It starts earlier, in the formula and the claim a brand expects to place on pack. By the time artwork is approved, an error may already be embedded in the product concept.
Executives therefore need more than a final label check. The stronger service model tests whether ingredients are permitted, whether dosage limits fit the intended market, whether warnings are complete and whether proposed claims can be supported by the formula. Early review matters because claim strategy often influences formulation. A product developed without that link can reach the artwork stage with little room to correct the underlying issue.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Practical interpretation is another dividing line. Regulation does not always produce a simple yes or no answer. Enforcement patterns and retailer expectations can affect how a rule is applied. A useful adviser should explain the legal position while also showing what a brand can realistically change. Buyers should be wary of reviews that merely list defects and leave internal teams to decide how to repair them.
Human judgment also remains central. Automated tools can assist research, but label reviews require context that is difficult to reduce to fixed rules. Health claims and translated text can look acceptable in isolation while becoming misleading once the full pack and intended audience are considered. A reviewer must also recognise familiar errors produced by generic prompts or literal translation.
International expansion introduces another layer of exposure. Rules that appear broadly aligned between the UK and EU can diverge at ingredient and dosage level. A label prepared for one country may need revised text, local business details, market-specific warnings and a separate product notification elsewhere. US requirements differ more sharply, especially around supplement facts and permissible claims. Buyers should look for support that begins with market selection and continues through formula review, label preparation, local representation and registration where required.
Service responsiveness should also be tested against the buyer’s working rhythm. Small questions can prevent expensive rework, but only when answers arrive before print deadlines or retailer submissions. Ongoing access may therefore matter as much as the initial review. The strongest providers reduce avoidable back-and-forth while keeping the brand’s commercial objective visible. They should also be comfortable entering late, identifying what can still be corrected and separating urgent defects from lower-priority refinements.
Check My Label is a strong choice for supplement businesses that need practical compliance advice rather than a rule summary. It supports formulation review and label development, alongside guidance for advertising and post-launch questions. Its service spans the UK and EU, with support for US market entry where required. Its work includes translated label text, EU food business operator arrangements, product notification and market-specific claim review. Human-led assessment remains central, allowing legal requirements to be weighed against market context and enforcement practice. This makes it well suited to brands preparing a launch, correcting an existing label, entering new markets or maintaining compliance across an established range.
More in News